Literature DB >> 26753095

Ambiguine I Isonitrile from Fischerella ambigua Induces Caspase-Independent Cell Death in MCF-7 Hormone Dependent Breast Cancer Cells.

Ulyana Muñoz Acuña1, Jiachen Zi2, Jimmy Orjala2, Esperanza J Carcache de Blanco1.   

Abstract

Ambiguine I isonitrile (AmbI) obtained from the cultured cyanobacterium Fischerella ambigua was identified as a potent NF-κB inhibitor (IC50=30 nM). The cytotoxic effect was evaluated in both HT-29 colon cancer cell line (EC50=4.35 μM) and MCF-7 breast cancer cell line (EC50=1.7 μM) using the SRB assay. In the cells treated with AmbI, an increased population of cells was detected in sub G1-phase. The apoptotic effect was associated with block in G1-phase of the cell cycle in treated cells; however, cell death was induced independently of caspase-7. The NF-κB expression of p50 and p65 units were also examined in treated cells and compared with the positive control, rocaglamide (IC50=75 nM). Moreover, the expression of mediators of the NF-κB pathway such as kinase IKKκ was studied at increasing concentrations of AmbI. The down stream effect of NF-κB inhibition and the effect on the expression of TNF-α induced ICAM-1 was evaluated. Thus, the dose-dependent and time-dependent effect of AmbI on MCF-7 cells was examined in an attempt to investigate its potential mechanism of action on inducing apoptosis.

Entities:  

Keywords:  Ambiguine I isonitrile; MCF-7; NF-κB; ROS; apoptosis; caspase-independent; mitochondria

Year:  2015        PMID: 26753095      PMCID: PMC4703120     

Source DB:  PubMed          Journal:  Int J Cancer Res (Tortola)        ISSN: 2051-784X


  25 in total

Review 1.  Transcription factors as targets for cancer therapy.

Authors:  James E Darnell
Journal:  Nat Rev Cancer       Date:  2002-10       Impact factor: 60.716

2.  Blockade of histone deacetylase inhibitor-induced RelA/p65 acetylation and NF-kappaB activation potentiates apoptosis in leukemia cells through a process mediated by oxidative damage, XIAP downregulation, and c-Jun N-terminal kinase 1 activation.

Authors:  Yun Dai; Mohamed Rahmani; Paul Dent; Steven Grant
Journal:  Mol Cell Biol       Date:  2005-07       Impact factor: 4.272

3.  Gene expression of the invasive phenotype of TNF-alpha-treated MCF-7 cells.

Authors:  Yongmei Yin; Xiaofeng Chen; Yongqian Shu
Journal:  Biomed Pharmacother       Date:  2009-06-13       Impact factor: 6.529

4.  Isolation and characterization of minor analogues of silvestrol and other constituents from a large-scale re-collection of Aglaia foveolata.

Authors:  Li Pan; Leonardus B S Kardono; Soedarsono Riswan; Heebyung Chai; Esperanza J Carcache de Blanco; Caroline M Pannell; Djaja Doel Soejarto; Thomas G McCloud; David J Newman; A Douglas Kinghorn
Journal:  J Nat Prod       Date:  2010-10-12       Impact factor: 4.050

5.  NF-kappaB inhibitors from Brucea javanica exhibiting intracellular effects on reactive oxygen species.

Authors:  Jeong-Ah Kim; Edward K Lau; Li Pan; Esperanza J Carcache De Blanco
Journal:  Anticancer Res       Date:  2010-09       Impact factor: 2.480

6.  Resveratrol inhibits tumor cell adhesion to endothelial cells by blocking ICAM-1 expression.

Authors:  Jung Sun Park; Ki Min Kim; Mi Ha Kim; Hee Jung Chang; Min Kyung Baek; Seok Mo Kim; Young Do Jung
Journal:  Anticancer Res       Date:  2009-01       Impact factor: 2.480

7.  Celecoxib decreases expression of the adhesion molecules ICAM-1 and VCAM-1 in a colon cancer cell line (HT29).

Authors:  M Gallicchio; A C Rosa; C Dianzani; L Brucato; E Benetti; M Collino; R Fantozzi
Journal:  Br J Pharmacol       Date:  2007-12-17       Impact factor: 8.739

8.  Celecoxib modulates adhesion of HT29 colon cancer cells to vascular endothelial cells by inhibiting ICAM-1 and VCAM-1 expression.

Authors:  C Dianzani; L Brucato; M Gallicchio; A C Rosa; M Collino; R Fantozzi
Journal:  Br J Pharmacol       Date:  2007-12-17       Impact factor: 8.739

9.  Pharmacologic IKK/NF-κB inhibition causes antigen presenting cells to undergo TNFα dependent ROS-mediated programmed cell death.

Authors:  Jeremy S Tilstra; Daniel F Gaddy; Jing Zhao; Shaival H Davé; Laura J Niedernhofer; Scott E Plevy; Paul D Robbins
Journal:  Sci Rep       Date:  2014-01-10       Impact factor: 4.379

10.  NF-kappa B genes have a major role in inflammatory breast cancer.

Authors:  Florence Lerebours; Sophie Vacher; Catherine Andrieu; Marc Espie; Michel Marty; Rosette Lidereau; Ivan Bieche
Journal:  BMC Cancer       Date:  2008-02-04       Impact factor: 4.430

View more
  6 in total

1.  Hapalindole H Induces Apoptosis as an Inhibitor of NF-ĸB and Affects the Intrinsic Mitochondrial Pathway in PC-3 Androgen-insensitive Prostate Cancer Cells.

Authors:  Ulyana Muñoz Acuña; Shunyan Mo; Jiachen Zi; Jimmy Orjala; Esperanza J Carcache DE Blanco
Journal:  Anticancer Res       Date:  2018-06       Impact factor: 2.480

Review 2.  Discovery of Anticancer Agents of Diverse Natural Origin.

Authors:  A Douglas Kinghorn; Esperanza J Carcache DE Blanco; David M Lucas; H Liva Rakotondraibe; Jimmy Orjala; D Doel Soejarto; Nicholas H Oberlies; Cedric J Pearce; Mansukh C Wani; Brent R Stockwell; Joanna E Burdette; Steven M Swanson; James R Fuchs; Mitchell A Phelps; Lihui Xu; Xiaoli Zhang; Young Yongchun Shen
Journal:  Anticancer Res       Date:  2016-11       Impact factor: 2.480

Review 3.  Bacterial terpenome.

Authors:  Jeffrey D Rudolf; Tyler A Alsup; Baofu Xu; Zining Li
Journal:  Nat Prod Rep       Date:  2021-05-26       Impact factor: 15.111

Review 4.  Indole Alkaloids of the Stigonematales (Cyanophyta): Chemical Diversity, Biosynthesis and Biological Activity.

Authors:  Katherine Walton; John P Berry
Journal:  Mar Drugs       Date:  2016-04-06       Impact factor: 5.118

Review 5.  Molecular basis for the plasticity of aromatic prenyltransferases in hapalindole biosynthesis.

Authors:  Takayoshi Awakawa; Ikuro Abe
Journal:  Beilstein J Org Chem       Date:  2019-07-11       Impact factor: 2.883

6.  Total Synthesis of the Chlorinated Pentacyclic Indole Alkaloid (+)-Ambiguine G.

Authors:  Lingbowei Hu; Viresh H Rawal
Journal:  J Am Chem Soc       Date:  2021-07-19       Impact factor: 15.419

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.